SPONTANEOUS REGRESSION OF RESTENOSIS - AN ANGIOGRAPHIC STUDY

被引:30
作者
MEHTA, VY
JORGENSEN, MB
RAIZNER, AE
WOLDETSADIK, G
MAHRER, PR
MANSUKHANI, P
机构
[1] KAISER PERMANENTE MED CTR,DEPT INTERNAL MED,CARDIOL SECT,LOS ANGELES,CA
[2] BAYLOR COLL MED,DEPT INTERNAL MED,CARDIOL SECT,HOUSTON,TX
关键词
D O I
10.1016/0735-1097(95)00335-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. This study was designed to examine the possibility that spontaneous regression in stenosis severity occurs over time in patients with restenosis after percutaneous transluminal coronary angioplasty. Background. The underlying mechanisms of restenosis are intimal hyperplasia and smooth muscle cell proliferation in response to vascular injury, We hypothesized that the initial hyperplastic response is followed by dynamic remodeling and eventual spontaneous regression, leading to stabilization or a reduction in stenosis severity. Methods. A total of 136 patients participated in a trial to evaluate the efficacy of fish oil versus placebo in preventing restenosis after angioplasty. One hundred thirteen patients completed this study with angiographic follow-up, of whom 56 had restenosis. Of these, 19 were asymptomatic and did not undergo repeat revascularization; 15 consented in a separate study to undergo repeat angiography, which was performed 6 to 25 months later to assess the possibility of regression. Results. There was a significant mean (+/-SD) decrease in lesion severity from 66.9 +/- 8.7% to 47.5 +/- 9.0% (p < 0.0001) and a significant mean increase in minimal lumen diameter from 0.91 +/- 0.31 mm to 1.44 +/- 0.35 mm (p < 0.0001). No patient shelved progression of stenosis, but regression of restenosis, defined as a decrease in minimal lumen diameter greater than or equal to 0.2 mm, was noted in 12 of the patients. Conclusions. Although all 15 study patients were asymptomatic, similar changes may occur in symptomatic patients. A trial of medical therapy may be appropriate in asymptomatic or mildly symptomatic patients before further interventions. This strategy would avoid unnecessary invasive procedures, prevent a ''restenosis cycle'' and result in significant cost savings.
引用
收藏
页码:696 / 702
页数:7
相关论文
共 71 条
[1]   INTIMAL PROLIFERATION OF SMOOTH-MUSCLE CELLS AS AN EXPLANATION FOR RECURRENT CORONARY-ARTERY STENOSIS AFTER PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY [J].
AUSTIN, GE ;
RATLIFF, NB ;
HOLLMAN, J ;
TABEI, S ;
PHILLIPS, DF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (02) :369-375
[2]   MORPHOLOGY AFTER TRANS-LUMINAL ANGIOPLASTY IN HUMAN-BEINGS [J].
BLOCK, PC ;
MYLER, RK ;
STERTZER, S ;
FALLON, JT .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (07) :382-385
[3]  
CAMPBELL GR, 1988, ARCH PATHOL LAB MED, V112, P977
[4]   ENDOTHELIAL-CELL INFLUENCES ON VASCULAR SMOOTH-MUSCLE PHENOTYPE [J].
CAMPBELL, JH ;
CAMPBELL, GR .
ANNUAL REVIEW OF PHYSIOLOGY, 1986, 48 :295-306
[5]   REGULATION OF VASCULAR SMOOTH-MUSCLE CELL-GROWTH BY HEPARIN AND HEPARAN SULFATES [J].
CASTELLOT, JJ ;
WRIGHT, TC ;
KARNOVSKY, MJ .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1987, 13 (04) :489-503
[6]   CULTURED ENDOTHELIAL-CELLS PRODUCE A HEPARIN-LIKE INHIBITOR OF SMOOTH-MUSCLE CELL-GROWTH [J].
CASTELLOT, JJ ;
ADDONIZIO, ML ;
ROSENBERG, R ;
KARNOVSKY, MJ .
JOURNAL OF CELL BIOLOGY, 1981, 90 (02) :372-379
[7]   SERUM CONTAINS A PLATELET-DERIVED TRANSFORMING GROWTH-FACTOR [J].
CHILDS, CB ;
PROPER, JA ;
TUCKER, RF ;
MOSES, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (17) :5312-5316
[8]  
CLARK RAF, 1988, MOL CELLULAR BIOL WO, P1
[9]  
CLOWES AW, 1989, LAB INVEST, V60, P360
[10]  
CLOWES AW, 1983, LAB INVEST, V49, P327